Zhuang Qihong, Zeng Yiming, Shi Yonghong
Respiratory Medicine, the First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
Respiratory Medicine, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China. Email:
Zhonghua Jie He He Hu Xi Za Zhi. 2014 Jun;37(6):406-10.
To explore and evaluate the predictive value of coagulopathy in patients with community-acquired pneumonia (CAP) METHODS: A retrospective study was performed by investigating the prothrombin time (PT), activated partial thromboplastin time (APTT), plasma fibrinogen (FIB), thrombin time (TT), platelets (PLT), and D-dimer in 385 patients with CAP, who were admitted to the Respiratory Medical Department of the First Affiliated Hospital of Xiamen University from June, 2010 to May, 2011. The differences of the aforementioned results in patients with different prognostic risks were compared and analyzed. The Pneumonia Severity Index (PSI) was calculated to assess the severity.
The serum levels of PT, TT and D-dimer in high-risk patients with CAP were (15.1 ± 1.4) s, (16.0 ± 1.8) s, (7.5 ± 8.3) mg/L, respectively. They were all increased compared with those in the low-risk group (14.5 ± 0.9) s, (15.4 ± 1.2) s, (1.6 ± 2.0) mg/L]; the differences being statistically significant (P < 0.001), while PLT, APTT, and FIB were not statistically different (P > 0.05). The difference of the abnormal rate of PLT, PT, and D-dimer in high-risk group and the low-risk group were 30% (45/148) and 20% (47/237), 18% (26/148) and 5% (13/237), 99% (146/148) and 85% (202/237), respectively, the differences being statistically significant (χ² value were 5.602, 14.609, 23.442, respectively, P < 0.05), while TT, APTT, FIB were not (P > 0.05). Rank correlation existed between D-dimer and PSI (r = 0.798, P < 0.001), while there was no correlation between PLT and PSI (χ² = 6.040, P > 0.05). D-dimer in patients with respiratory failure was (10.0 ± 9.9) mg/L, which was significantly increased compared with that in patients without respiratory failure (2.4 ± 3.6) mg/L, P < 0.001, and there was no significant difference in PLT (χ² = 3.457, P > 0.05). D-dimer was significantly higher in patients who died of pneumonia as compared to those who survived [(14.0 ± 8.8) mg/L, (2.8 ± 4.6) mg/L, P < 0.001], and there was a significant difference in PLT (χ² = 4.909, P < 0.05). The area under the receiver operator characteristic curve (ROC) of D-dimer, PSI and PLT were 0.962, 0.906, 0.583, respectively. Concerning the predictive value of mortality, both D-dimer and PSI showed ideal predictive accuracy (P < 0.001). The sensitivity of D-dimer was superior to its specificity. PLT showed poor predictive value for mortality.
D-dimer was significantly higher in patients with CAP. D-dimer level was positively correlated with severity and mortality. D-dimer could be a good biomarker to assess the severity and mortality of patients with CAP.
探讨并评估社区获得性肺炎(CAP)患者凝血功能障碍的预测价值。方法:采用回顾性研究方法,对2010年6月至2011年5月厦门大学附属第一医院呼吸内科收治的385例CAP患者的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、血浆纤维蛋白原(FIB)、凝血酶时间(TT)、血小板(PLT)及D-二聚体进行检测。比较分析上述结果在不同预后风险患者中的差异。计算肺炎严重程度指数(PSI)以评估病情严重程度。
CAP高危患者血清PT、TT及D-二聚体水平分别为(15.1±1.4)s、(16.0±1.8)s、(7.5±8.3)mg/L,均高于低危组[(14.5±0.9)s、(15.4±1.2)s、(1.6±2.0)mg/L],差异有统计学意义(P<0.001),而PLT、APTT及FIB差异无统计学意义(P>0.05)。高危组与低危组PLT、PT及D-二聚体异常率差异分别为30%(45/148)与20%(47/237)、18%(26/148)与5%(13/237)、99%(146/148)与85%(202/237),差异有统计学意义(χ²值分别为5.602、14.609、23.442,P<0.05),而TT、APTT、FIB差异无统计学意义(P>0.05)。D-二聚体与PSI呈等级相关(r=0.798,P<0.001),而PLT与PSI无相关性(χ²=6.040,P>0.05)。呼吸衰竭患者D-二聚体为(10.0±9.9)mg/L,明显高于无呼吸衰竭患者(2.4±3.6)mg/L,P<0.001,PLT差异无统计学意义(χ²=3.457,P>0.05)。肺炎死亡患者D-二聚体明显高于存活患者[(14.0±8.8)mg/L,(2.8±4.6)mg/L,P<0.001],PLT差异有统计学意义(χ²=4.909,P<0.05)。D-二聚体、PSI及PLT的受试者工作特征曲线(ROC)下面积分别为0.962、0.906、0.583。就死亡预测价值而言,D-二聚体和PSI均显示出理想的预测准确性(P<0.001)。D-二聚体的敏感性优于特异性。PLT对死亡的预测价值较差。
CAP患者D-二聚体明显升高。D-二聚体水平与病情严重程度及死亡率呈正相关。D-二聚体可作为评估CAP患者病情严重程度及死亡率的良好生物标志物。